Ingelheim, Germany, Mon, 16/09/2024 – 12:00 Boehringer Ingelheim announced today that the FIBRONEER™-IPF trial met its primary endpoint, which was the absolute change from baseline in Forced Vital Capacity [mL] (FVC) at week 52 versus placebo. FVC is Read More
DUBAI, UNITED ARAB EMIRATES, 18 September 2024 Migraine, a debilitating neurological disorder[1], affects over a billion people globally[2]. Today, Pfizer marks a significant milestone in its journey towards advancing healthcare in the UAE by introducing a groundbreaking Read More
Event Highlights Innovation in Longevity Medicine, AI, and Blockchain Technologies. Dubai, UAE; September 14, 2024 Biongevity, Dubai’s first longevity clinic, officially opened its doors on Friday, 13th September 2024, marking a significant milestone in the UAE’s Read More
Expansion aligns with the region’s vision of establishing Middle East as the health and longevity centre of the world. Holistic program THRIVE invites midlife individuals to an immersive rejuvenating reset. Dubai, UAE: 11th September 2024 Read More
DUBAI, UNITED ARAB EMIRATES, 5 September 2024 Pfizer announces the appointment of Elif Aral as Regional President for Middle East, Russia, and Africa (MERA) effective September 2024 to spearhead operations in the region and bring scientific breakthroughs in Read More
